Knowledge management solutions provider Aureus Pharma, France, has announced the release of three new AurSCOPE Target knowledge databases. The new offerings include knowledge databases for the important drug targets Nuclear Receptor and Protease, as well as the centralised product AurSCOPE Global Pharmacology Space (AurSCOPE GPS). AurSCOPE GPS comprises all of the pharmaceutically significant therapeutic targets including G-Protein coupled receptors (GPCR), kinases, ion channels, nuclear receptors and proteases.
AurSCOPE GPS and other AurSCOPE Knowledge databases streamline discovery efforts with thorough assessment of selectivity and off-target effects at the earliest stages of the drug discovery pipeline. The new databases are projected to considerably extend Aureus Pharma's knowledge management solution by providing pharmaceutical customers with access to the druggable therapeutic target space.
As a knowledge management based solutions provider for the life sciences industry, Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes as well as ADME/Tox topics.
